320 related articles for article (PubMed ID: 15302720)
1. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
[TBL] [Abstract][Full Text] [Related]
2. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Lung; 2006; 184(4):217-22. PubMed ID: 17006748
[TBL] [Abstract][Full Text] [Related]
3. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
4. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
6. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
7. Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD.
Chen YH; Yao WZ; Ding YL; Geng B; Lu M; Tang CS
Pulm Pharmacol Ther; 2008; 21(1):40-6. PubMed ID: 17196413
[TBL] [Abstract][Full Text] [Related]
8. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
[TBL] [Abstract][Full Text] [Related]
9. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
[TBL] [Abstract][Full Text] [Related]
10. Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD.
Lapperre TS; Willems LN; Timens W; Rabe KF; Hiemstra PS; Postma DS; Sterk PJ
Chest; 2007 Jan; 131(1):53-9. PubMed ID: 17218556
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function.
Balzano G; Stefanelli F; Iorio C; De Felice A; Melillo EM; Martucci M; Melillo G
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1486-92. PubMed ID: 10556110
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
13. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
[TBL] [Abstract][Full Text] [Related]
14. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
15. The success and safety profile of sputum induction in patients with chronic obstructive pulmonary disease: An Indian experience.
Fernandes L; Mesquita AM
Indian J Tuberc; 2017 Jul; 64(3):201-205. PubMed ID: 28709489
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
Lapperre TS; Snoeck-Stroband JB; Gosman MM; Stolk J; Sont JK; Jansen DF; Kerstjens HA; Postma DS; Sterk PJ;
Am J Respir Crit Care Med; 2004 Sep; 170(5):499-504. PubMed ID: 15172889
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator reversibility in COPD.
Hanania NA; Celli BR; Donohue JF; Martin UJ
Chest; 2011 Oct; 140(4):1055-1063. PubMed ID: 21972384
[TBL] [Abstract][Full Text] [Related]
19. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
